NCT00648778View on ClinicalTrials.gov

Fasting Study of Loxapine Succinate Capsules 25 mg and Loxitane® Capsules 25 mg

PHASE1CompletedINTERVENTIONAL
Enrollment

53

Participants

Timeline

Start Date

January 31, 2003

Primary Completion Date

February 28, 2003

Study Completion Date

February 28, 2003

Conditions
Healthy
Interventions
DRUG

Loxapine Succinate Capsules 25 mg

25mg, single dose fasting

DRUG

Loxitane® Capsules 25 mg

25mg, single dose fasting

Trial Locations (1)

26505

Kendle International Inc., Morgantown

Sponsors
All Listed Sponsors
lead

Mylan Pharmaceuticals Inc

INDUSTRY

NCT00648778 - Fasting Study of Loxapine Succinate Capsules 25 mg and Loxitane® Capsules 25 mg | Biotech Hunter | Biotech Hunter